Literature DB >> 16082688

No support for association between the dopamine transporter (DAT1) gene and ADHD.

K Langley1, D Turic, T R Peirce, S Mills, M B Van Den Bree, M J Owen, M C O'Donovan, A Thapar.   

Abstract

Several groups have reported an association between the 10-repeat allele of a dopamine transporter (DAT1) 3'UTR VNTR variant and ADHD but the finding has not been universally observed. An association between DAT1 genotype and stimulant medication response has also been reported although again there are conflicting data. We tested the DAT1 3'VNTR and three SNPs in the putative promoter region of DAT1 for association with ADHD in 263 parent-proband trios. Analyses of genotypes, alleles, and haplotypes were performed using family-based association methods. Case-control analysis of the VNTR in 263 cases and 287 controls was also conducted. In addition, we tested for association between the VNTR marker and stimulant medication response. Comparing allele 10 versus all other alleles combined, no significant association was found with ADHD, using FBAT analysis (chi2 = 0.1 (df 1), P = 0.9, (odds ratio (OR) = 1.0, 95% CI 0.8-1.2), and case-control analysis (chi2 = 0.12 (df 2), P = 0.91). No evidence of association with any of the SNPs in the promoter region was found. Haplotype analysis was also non-significant (chi2 = 3.93, (df 9) global P = 0.85). Finally, no association was found between the DAT 1 VNTR and response to stimulant medication (chi2 = 1.63 (df 3) P = 0.65). We conclude that the 3' VNTR and three additional promoter variants in DAT1 do not appear to be associated with ADHD, or response to stimulant mediation in our sample. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082688     DOI: 10.1002/ajmg.b.30206

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  23 in total

Review 1.  Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.

Authors:  Roberta Russo; Mario Capasso; Paolo Paolucci; Achille Iolascon
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

Review 2.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-04-28       Impact factor: 4.132

3.  Association among SNAP-25 gene DdeI and MnlI polymorphisms and hemodynamic changes during methylphenidate use: a functional near-infrared spectroscopy study.

Authors:  Özgür Öner; Ata Akın; Hasan Herken; Mehmet Emin Erdal; Koray Çiftçi; Mustafa Ertan Ay; Duygu Bicer; Bedriye Öncü; Ozlem Hekim Bozkurt; Kerim Münir; Yankı Yazgan
Journal:  J Atten Disord       Date:  2010-08-02       Impact factor: 3.256

4.  Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study.

Authors:  Corinde E Wiers; Falk W Lohoff; Jisoo Lee; Christine Muench; Clara Freeman; Amna Zehra; Stefano Marenco; Barbara K Lipska; Pavan K Auluck; Ningping Feng; Hui Sun; David Goldman; James M Swanson; Gene-Jack Wang; Nora D Volkow
Journal:  Eur J Neurosci       Date:  2018-08       Impact factor: 3.386

5.  Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder.

Authors:  Kate Langley; Tom A Fowler; Deborah L Grady; Robert K Moyzis; Peter A Holmans; Marianne B M van den Bree; Michael J Owen; Michael C O'Donovan; Anita Thapar
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-06-18       Impact factor: 4.785

Review 6.  Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

Authors:  Tanya E Froehlich; James J McGough; Mark A Stein
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 7.  Genetic aspects in attention-deficit/hyperactivity disorder.

Authors:  O Albayrak; S Friedel; B G Schimmelmann; A Hinney; J Hebebrand
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

8.  Association study between the dopamine-related candidate gene polymorphisms and ADHD among Saudi Arabia population via PCR technique.

Authors:  Adel E El-Tarras; Adnan A Alsulaimani; Nabil S Awad; Nahla Mitwaly; Manal M Said; Ayman M Sabry
Journal:  Mol Biol Rep       Date:  2012-10-18       Impact factor: 2.316

Review 9.  The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy.

Authors:  Mark A Stein; James J McGough
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-04

10.  Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder.

Authors:  Xiaohui Xu; Jonathan Mill; Bo Sun; Chih-Ken Chen; Yu-Shu Huang; Yu-Yu Wu; Philip Asherson
Journal:  BMC Psychiatry       Date:  2009-02-05       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.